Herantis Pharma Plc’s financial reporting in 2015

Herantis Pharma Plc's financial reporting in 2015
Herantis Pharma Plc.
Company release 18 December 2014 at 10:00 am

Herantis Pharma will publish the following financial reports in 2015:

  * Financial Statements bulletin in regard to 2014 on Friday the 27th of
    February 2015
  * Interim Report on January-June 2015 on Wednesday the 19th of August 2015

The  Annual General Meeting is  planned to be held  on Thursday the 9th of April
2015. The  Board of Directors will present a formal notice of the AGM at a later

Annual  Report for 2014 will be published  during the week 13/2015 in electronic
format on the company's web site.

Further information:

Herantis Pharma Plc., Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Capital Oy, telephone: +358 9 2538 0225

About Herantis Pharma Plc.

Herantis  Pharma  Plc.  is  a  pharmaceutical  company  specialised  in new drug
research and development. The company focuses on diseases with an unmet clinical
need.  These diseases include for example dry eye syndrome, Parkinson's disease,
and  secondary lymphedema. We believe  our drugs are the  first or best in their
class  and have  the potential  to change  treatment strategies of diseases. The
shares of Herantis Pharma Plc. are listed on the First North Finland marketplace
run by NASDAQ Helsinki stock exchange.